Home › Companies › ARROWHEAD PHARMACEUTICALS INC. › 2023-2024
Compiled from SEC Form N-PX filings and ARROWHEAD PHARMACEUTICALS INC.’s Form 8-K, filed 2024-03-19 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore ARROWHEAD PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are ARROWHEAD PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-03-19 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Douglass Given | 76,397,567 | 10,968,346 | 303,938 | -- | -- | Majority: yes |
| Elect Director: Michael S. Perry | 82,446,900 | 4,911,855 | 311,096 | -- | -- | Majority: yes |
| Elect Director: Christopher Anzalone | 84,313,696 | 2,976,660 | 379,495 | -- | -- | Majority: yes |
| Elect Director: Mauro Ferrari | 81,342,884 | 6,020,799 | 306,168 | -- | -- | Majority: yes |
| Elect Director: Adeoye Olukoton | 83,526,809 | 3,815,731 | 327,311 | -- | -- | Majority: yes |
| Elect Director: William Waddill | 83,279,633 | 4,079,251 | 310,967 | -- | -- | Majority: yes |
| Elect Director: Victoria Vakiener | 83,354,988 | 3,975,617 | 339,246 | -- | -- | Majority: yes |
Source: ARROWHEAD PHARMACEUTICALS INC., Form 8-K, filed with the SEC on 2024-03-19 — read the filing on EDGAR.
Each item below shows how the 305 asset managers that disclosed a ARROWHEAD PHARMACEUTICALS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of ARROWHEAD PHARMACEUTICALS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 3 wordings of this item as funds reported it.
99.3% fund support · no official result
The 287 asset managers below cast 99.3% of the shares they voted on this item FOR (105,148,888 for, 735,188 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Lazard | 19,000,000 | 0 | 0 | 0 | For |
| Fidelity | 14,610,245 | 0 | 0 | 0 | For |
| BlackRock | 12,779,233 | 539 | 0 | 0 | For |
| Vanguard | 11,145,037 | 0 | 0 | 0 | For |
| State Street | 10,477,729 | 0 | 0 | 0 | For |
| Avoro Capital Advisors LLC | 6,983,630 | 0 | 0 | 0 | For |
| Capital Group | 3,066,120 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,634,955 | 0 | 0 | 0 | For |
| Charles Schwab | 1,941,754 | 0 | 0 | 0 | For |
| JPMorgan | 1,689,642 | 0 | 0 | 0 | For |
| UBS | 1,676,058 | 0 | 0 | 0 | For |
| Slate Path Capital LP | 1,416,991 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 1,287,207 | 0 | 0 | 0 | For |
| Avidity Partners Management LP | 1,184,524 | 0 | 0 | 0 | For |
| Aquilo Capital Management, LLC | 0 | 0 | 908,474 | 0 | Abstain |
| Columbia Threadneedle | 860,818 | 0 | 0 | 0 | For |
| T. Rowe Price | 806,342 | 0 | 0 | 0 | For |
| ORBIMED ADVISORS LLC | 739,651 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 624,000 | 0 | 0 | 0 | For |
| Invesco | 478,737 | 0 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 470,038 | 0 | 0 | 0 | For |
| Equitable | 454,285 | 0 | 0 | 0 | For |
| Citadel | 427,962 | 0 | 0 | 0 | For |
| First Light Asset Management, LLC | 425,963 | 0 | 0 | 0 | For |
| Voya | 400,855 | 0 | 0 | 0 | For |
Showing the 25 largest of 287 asset managers. See all 287 in the interactive database.
Combines 3 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
ARROWHEAD PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Adeoye Olukoton”): 83,526,809 for, 3,815,731 against, per its Form 8-K filed 2024-03-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 107,500,000 outstanding shares: 78% for, 4% against (81% of the company cast a for/against vote).
The 79 asset managers below cast 99.6% of the shares they voted on this item FOR (42,027,042 for, 135,480 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,801,253 | 0 | 0 | 0 | For |
| BlackRock | 8,862,994 | 0 | 0 | 0 | For |
| Fidelity | 8,258,129 | 0 | 0 | 0 | For |
| State Street | 3,855,550 | 0 | 0 | 0 | For |
| Capital Group | 1,533,060 | 0 | 0 | 0 | For |
| JPMorgan | 1,422,450 | 0 | 0 | 0 | For |
| Charles Schwab | 970,877 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 860,818 | 0 | 0 | 0 | For |
| Equitable | 454,285 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 369,981 | 0 | 0 | 0 | For |
| Jackson National | 369,872 | 0 | 0 | 0 | For |
| TIAA | 327,657 | 0 | 0 | 0 | For |
| T. Rowe Price | 325,134 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 313,289 | 0 | 0 | 0 | For |
| Dimensional | 280,720 | 0 | 0 | 0 | For |
| Invesco | 216,044 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 211,712 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 207,440 | 0 | 0 | 0 | For |
| Voya | 176,844 | 0 | 0 | 0 | For |
| Russell Investments | 172,870 | 0 | 0 | 0 | For |
| Global X | 168,934 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 156,618 | 0 | 0 | 0 | For |
| Northern Trust | 141,129 | 0 | 0 | 0 | For |
| Lincoln Financial | 135,237 | 0 | 0 | 0 | For |
| Brighthouse | 91,763 | 0 | 38,587 | 0 | For |
Showing the 25 largest of 79 asset managers. See all 79 in the interactive database.
Combines 3 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
ARROWHEAD PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Christopher Anzalone”): 84,313,696 for, 2,976,660 against, per its Form 8-K filed 2024-03-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 107,500,000 outstanding shares: 78% for, 3% against (81% of the company cast a for/against vote).
The 79 asset managers below cast 99.9% of the shares they voted on this item FOR (42,153,040 for, 9,482 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,801,253 | 0 | 0 | 0 | For |
| BlackRock | 8,862,994 | 0 | 0 | 0 | For |
| Fidelity | 8,258,129 | 0 | 0 | 0 | For |
| State Street | 3,855,550 | 0 | 0 | 0 | For |
| Capital Group | 1,533,060 | 0 | 0 | 0 | For |
| JPMorgan | 1,422,450 | 0 | 0 | 0 | For |
| Charles Schwab | 970,877 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 860,818 | 0 | 0 | 0 | For |
| Equitable | 454,285 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 369,981 | 0 | 0 | 0 | For |
| Jackson National | 369,872 | 0 | 0 | 0 | For |
| TIAA | 327,657 | 0 | 0 | 0 | For |
| T. Rowe Price | 325,134 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 313,289 | 0 | 0 | 0 | For |
| Dimensional | 280,720 | 0 | 0 | 0 | For |
| Invesco | 216,044 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 211,712 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 207,440 | 0 | 0 | 0 | For |
| Voya | 176,844 | 0 | 0 | 0 | For |
| Russell Investments | 172,870 | 0 | 0 | 0 | For |
| Global X | 168,934 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 156,618 | 0 | 0 | 0 | For |
| Northern Trust | 141,129 | 0 | 0 | 0 | For |
| Lincoln Financial | 135,237 | 0 | 0 | 0 | For |
| Brighthouse | 91,763 | 0 | 38,587 | 0 | For |
Showing the 25 largest of 79 asset managers. See all 79 in the interactive database.
Combines 3 wordings of this item as funds reported it.
87% Majority: yes · of votes cast
ARROWHEAD PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Douglass Given”): 76,397,567 for, 10,968,346 against, per its Form 8-K filed 2024-03-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 107,500,000 outstanding shares: 71% for, 10% against (81% of the company cast a for/against vote).
The 79 asset managers below cast 88% of the shares they voted on this item FOR (37,110,234 for, 5,052,288 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,801,253 | 0 | 0 | 0 | For |
| BlackRock | 8,862,994 | 0 | 0 | 0 | For |
| Fidelity | 8,258,129 | 0 | 0 | 0 | For |
| State Street | 0 | 3,855,550 | 0 | 0 | Against |
| Capital Group | 1,533,060 | 0 | 0 | 0 | For |
| JPMorgan | 1,422,450 | 0 | 0 | 0 | For |
| Charles Schwab | 970,877 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 860,818 | 0 | 0 | Against |
| Equitable | 454,285 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 369,981 | 0 | 0 | 0 | For |
| Jackson National | 369,872 | 0 | 0 | 0 | For |
| TIAA | 327,657 | 0 | 0 | 0 | For |
| T. Rowe Price | 325,134 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 313,289 | 0 | 0 | 0 | For |
| Dimensional | 280,720 | 0 | 0 | 0 | For |
| Invesco | 216,044 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 211,712 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 207,440 | 0 | 0 | 0 | For |
| Voya | 176,844 | 0 | 0 | 0 | For |
| Russell Investments | 172,870 | 0 | 0 | 0 | For |
| Global X | 168,934 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 156,618 | 0 | 0 | 0 | For |
| Northern Trust | 141,129 | 0 | 0 | 0 | For |
| Lincoln Financial | 6,774 | 128,463 | 0 | 0 | Against |
| Brighthouse | 91,763 | 0 | 38,587 | 0 | For |
Showing the 25 largest of 79 asset managers. See all 79 in the interactive database.
Combines 3 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
ARROWHEAD PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Mauro Ferrari”): 81,342,884 for, 6,020,799 against, per its Form 8-K filed 2024-03-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 107,500,000 outstanding shares: 76% for, 6% against (81% of the company cast a for/against vote).
The 79 asset managers below cast 99% of the shares they voted on this item FOR (41,577,417 for, 585,105 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,801,253 | 0 | 0 | 0 | For |
| BlackRock | 8,862,994 | 0 | 0 | 0 | For |
| Fidelity | 8,258,129 | 0 | 0 | 0 | For |
| State Street | 3,855,550 | 0 | 0 | 0 | For |
| Capital Group | 1,533,060 | 0 | 0 | 0 | For |
| JPMorgan | 1,422,450 | 0 | 0 | 0 | For |
| Charles Schwab | 970,877 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 860,818 | 0 | 0 | 0 | For |
| Equitable | 454,285 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 369,981 | 0 | 0 | 0 | For |
| Jackson National | 369,872 | 0 | 0 | 0 | For |
| TIAA | 327,657 | 0 | 0 | 0 | For |
| T. Rowe Price | 325,134 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 313,289 | 0 | 0 | 0 | For |
| Dimensional | 280,720 | 0 | 0 | 0 | For |
| Invesco | 216,044 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 211,712 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 207,440 | 0 | 0 | 0 | For |
| Voya | 176,844 | 0 | 0 | 0 | For |
| Russell Investments | 172,870 | 0 | 0 | 0 | For |
| Global X | 0 | 168,934 | 0 | 0 | Against |
| CARILLON SERIES TRUST | 156,618 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 141,129 | 0 | 0 | Against |
| Lincoln Financial | 135,237 | 0 | 0 | 0 | For |
| Brighthouse | 91,763 | 0 | 38,587 | 0 | For |
Showing the 25 largest of 79 asset managers. See all 79 in the interactive database.
Combines 3 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
ARROWHEAD PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Michael S. Perry”): 82,446,900 for, 4,911,855 against, per its Form 8-K filed 2024-03-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 107,500,000 outstanding shares: 77% for, 5% against (81% of the company cast a for/against vote).
The 79 asset managers below cast 99.6% of the shares they voted on this item FOR (42,028,875 for, 133,647 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,801,253 | 0 | 0 | 0 | For |
| BlackRock | 8,862,994 | 0 | 0 | 0 | For |
| Fidelity | 8,258,129 | 0 | 0 | 0 | For |
| State Street | 3,855,550 | 0 | 0 | 0 | For |
| Capital Group | 1,533,060 | 0 | 0 | 0 | For |
| JPMorgan | 1,422,450 | 0 | 0 | 0 | For |
| Charles Schwab | 970,877 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 860,818 | 0 | 0 | 0 | For |
| Equitable | 454,285 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 369,981 | 0 | 0 | 0 | For |
| Jackson National | 369,872 | 0 | 0 | 0 | For |
| TIAA | 327,657 | 0 | 0 | 0 | For |
| T. Rowe Price | 325,134 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 313,289 | 0 | 0 | 0 | For |
| Dimensional | 280,720 | 0 | 0 | 0 | For |
| Invesco | 216,044 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 211,712 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 207,440 | 0 | 0 | 0 | For |
| Voya | 176,844 | 0 | 0 | 0 | For |
| Russell Investments | 172,870 | 0 | 0 | 0 | For |
| Global X | 168,934 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 156,618 | 0 | 0 | 0 | For |
| Northern Trust | 141,129 | 0 | 0 | 0 | For |
| Lincoln Financial | 135,237 | 0 | 0 | 0 | For |
| Brighthouse | 91,763 | 0 | 38,587 | 0 | For |
Showing the 25 largest of 79 asset managers. See all 79 in the interactive database.
Combines 3 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
ARROWHEAD PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Victoria Vakiener”): 83,354,988 for, 3,975,617 against, per its Form 8-K filed 2024-03-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 107,500,000 outstanding shares: 78% for, 4% against (81% of the company cast a for/against vote).
The 79 asset managers below cast 99.0% of the shares they voted on this item FOR (41,746,322 for, 414,041 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,801,253 | 0 | 0 | 0 | For |
| BlackRock | 8,862,994 | 0 | 0 | 0 | For |
| Fidelity | 8,258,129 | 0 | 0 | 0 | For |
| State Street | 3,855,550 | 0 | 0 | 0 | For |
| Capital Group | 1,533,060 | 0 | 0 | 0 | For |
| JPMorgan | 1,422,450 | 0 | 0 | 0 | For |
| Charles Schwab | 970,877 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 860,818 | 0 | 0 | 0 | For |
| Equitable | 454,285 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 369,981 | 0 | 0 | 0 | For |
| Jackson National | 369,872 | 0 | 0 | 0 | For |
| TIAA | 327,657 | 0 | 0 | 0 | For |
| T. Rowe Price | 325,134 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 313,289 | 0 | 0 | 0 | For |
| Dimensional | 0 | 280,720 | 0 | 0 | Against |
| Invesco | 216,044 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 211,712 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 207,440 | 0 | 0 | 0 | For |
| Voya | 176,844 | 0 | 0 | 0 | For |
| Russell Investments | 172,870 | 0 | 0 | 0 | For |
| Global X | 168,934 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 156,618 | 0 | 0 | 0 | For |
| Northern Trust | 141,129 | 0 | 0 | 0 | For |
| Lincoln Financial | 135,237 | 0 | 0 | 0 | For |
| Brighthouse | 91,763 | 0 | 38,587 | 0 | For |
Showing the 25 largest of 79 asset managers. See all 79 in the interactive database.
Combines 3 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
ARROWHEAD PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: William Waddill”): 83,279,633 for, 4,079,251 against, per its Form 8-K filed 2024-03-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 107,500,000 outstanding shares: 77% for, 4% against (81% of the company cast a for/against vote).
The 79 asset managers below cast 99.6% of the shares they voted on this item FOR (42,028,875 for, 133,647 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,801,253 | 0 | 0 | 0 | For |
| BlackRock | 8,862,994 | 0 | 0 | 0 | For |
| Fidelity | 8,258,129 | 0 | 0 | 0 | For |
| State Street | 3,855,550 | 0 | 0 | 0 | For |
| Capital Group | 1,533,060 | 0 | 0 | 0 | For |
| JPMorgan | 1,422,450 | 0 | 0 | 0 | For |
| Charles Schwab | 970,877 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 860,818 | 0 | 0 | 0 | For |
| Equitable | 454,285 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 369,981 | 0 | 0 | 0 | For |
| Jackson National | 369,872 | 0 | 0 | 0 | For |
| TIAA | 327,657 | 0 | 0 | 0 | For |
| T. Rowe Price | 325,134 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 313,289 | 0 | 0 | 0 | For |
| Dimensional | 280,720 | 0 | 0 | 0 | For |
| Invesco | 216,044 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 211,712 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 207,440 | 0 | 0 | 0 | For |
| Voya | 176,844 | 0 | 0 | 0 | For |
| Russell Investments | 172,870 | 0 | 0 | 0 | For |
| Global X | 168,934 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 156,618 | 0 | 0 | 0 | For |
| Northern Trust | 141,129 | 0 | 0 | 0 | For |
| Lincoln Financial | 135,237 | 0 | 0 | 0 | For |
| Brighthouse | 91,763 | 0 | 38,587 | 0 | For |
Showing the 25 largest of 79 asset managers. See all 79 in the interactive database.
Combines 2 wordings of this item as funds reported it.
100% fund support · no official result
The 78 asset managers below cast 100% of the shares they voted on this item FOR (42,106,469 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,801,253 | 0 | 0 | 0 | For |
| BlackRock | 8,862,994 | 0 | 0 | 0 | For |
| Fidelity | 8,258,129 | 0 | 0 | 0 | For |
| State Street | 3,855,550 | 0 | 0 | 0 | For |
| Capital Group | 1,533,060 | 0 | 0 | 0 | For |
| JPMorgan | 1,422,450 | 0 | 0 | 0 | For |
| Charles Schwab | 970,877 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 860,818 | 0 | 0 | 0 | For |
| Equitable | 454,285 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 369,981 | 0 | 0 | 0 | For |
| Jackson National | 369,872 | 0 | 0 | 0 | For |
| TIAA | 327,657 | 0 | 0 | 0 | For |
| T. Rowe Price | 325,134 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 313,289 | 0 | 0 | 0 | For |
| Dimensional | 280,720 | 0 | 0 | 0 | For |
| Invesco | 216,044 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 211,712 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 207,440 | 0 | 0 | 0 | For |
| Voya | 176,844 | 0 | 0 | 0 | For |
| Russell Investments | 172,870 | 0 | 0 | 0 | For |
| Global X | 168,934 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 156,618 | 0 | 0 | 0 | For |
| Northern Trust | 141,129 | 0 | 0 | 0 | For |
| Lincoln Financial | 135,237 | 0 | 0 | 0 | For |
| Brighthouse | 91,763 | 0 | 38,587 | 0 | For |
Showing the 25 largest of 78 asset managers. See all 78 in the interactive database.
96% fund support · no official result
The 11 asset managers below cast 96% of the shares they voted on this item FOR (3,469,401 for, 155,711 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JPMorgan | 2,140,873 | 0 | 0 | 0 | For |
| Rokos Capital Management LLP | 1,229,148 | 0 | 0 | 0 | For |
| NORDEA INVESTMENT MANAGEMENT AB | 0 | 154,837 | 0 | 0 | Against |
| Empower | 56,053 | 0 | 0 | 0 | For |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 21,643 | 0 | 0 | 0 | For |
| Metzler Asset Management GmbH | 18,705 | 0 | 0 | 0 | For |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Ma | 1,700 | 0 | 0 | 0 | For |
| Desjardins Global Asset Management Inc. | 0 | 874 | 0 | 0 | Against |
| ALGERT GLOBAL LLC | 840 | 0 | 0 | 0 | For |
| Hanson & Doremus Investment Management | 320 | 0 | 0 | 0 | For |
| Uniplan Investment Counsel, Inc. | 119 | 0 | 0 | 0 | For |
100% fund support · no official result
The 3 asset managers below cast 100% of the shares they voted on this item FOR (30,271 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Osher Van de Voorde Investment Management | 15,155 | 0 | 0 | 0 | For |
| Ultimus Managers Trust | 14,316 | 0 | 0 | 0 | For |
| Aristides Capital LLC | 800 | 0 | 0 | 0 | For |
Ranked by the number of ARROWHEAD PHARMACEUTICALS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 107,500,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Lazard | 17.67% |
| 2 | Fidelity | 13.59% |
| 3 | BlackRock | 11.89% |
| 4 | Vanguard | 10.37% |
| 5 | State Street | 9.75% |
| 6 | Avoro Capital Advisors LLC | 6.50% |
| 7 | Capital Group | 2.85% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 2.45% |
| 9 | Charles Schwab | 1.81% |
| 10 | JPMorgan | 1.57% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 18.81% | 13F |
| Vanguard Group | 14.92% | 13F |
| State Street | 6.10% | 13F |
| FMR (Fidelity) | 5.36% | 13F |
| Christopher Anzalone | 3.46% | DEF14A |
| Geode Capital | 2.56% | 13F |
| Goldman Sachs | 1.70% | 13F |
| Morgan Stanley | 1.58% | 13F |
| Northern Trust | 1.21% | 13F |
| Norges Bank | 1.17% | 13F |
Percentages above are of 107,500,000 shares outstanding, as reported by ARROWHEAD PHARMACEUTICALS INC. on its Form 10-Q dated 2023-12-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ARROWHEAD PHARMACEUTICALS INC.’s 10-Q dated 2023-12-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At ARROWHEAD PHARMACEUTICALS INC.'s shareholder meeting held 2024-03-14, in the 2023-2024 proxy season, 305 asset managers reported how they voted in their SEC Form N-PX filings, covering 3,008 separate fund positions. Their filings are grouped here into 11 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. ARROWHEAD PHARMACEUTICALS INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION. — the reporting funds cast 99.3% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.
ARROWHEAD PHARMACEUTICALS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.